Chihiro Sugimoto Selected Research

Infections

1/2021	Molecular detection and characterization of tick-borne hemoparasites and Anaplasmataceae in dogs in major cities of Malawi.
10/2020	The Lethal(2)-Essential-for-Life [L(2)EFL] Gene Family Modulates Dengue Virus Infection in Aedes aegypti.
1/2018	Targeting of RNA Polymerase II by a nuclear Legionella pneumophila Dot/Icm effector SnpL.
4/2016	Molecular identification of the Cryptosporidium deer genotype in the Hokkaido sika deer (Cervus nippon yesoensis) in Hokkaido, Japan.
1/2013	Protochlamydia induces apoptosis of human HEp-2 cells through mitochondrial dysfunction mediated by chlamydial protease-like activity factor.
8/2010	Serodiagnosis of ovine toxoplasmosis in Mongolia by an enzyme-linked immunosorbent assay with recombinant Toxoplasma gondii matrix antigen 1.
5/2010	Detection of Trypanosoma cruzi and T. rangeli infections from Rhodnius pallescens bugs by loop-mediated isothermal amplification (LAMP).
2/2009	A perspective on Theileria equi infections in donkeys.
9/2008	The development and evaluation of a loop-mediated isothermal amplification (LAMP) method for detection of Babesia spp. infective to sheep and goats in China.
8/2008	Effect of CD4+CD25+ T cell-depletion on acute lethal infection of mice with Trypanosoma congolense.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chihiro Sugimoto Research Topics

Disease

14	Infections 01/2021 - 10/2003
5	Malaria 11/2020 - 08/2009
4	Toxoplasmosis 08/2010 - 10/2006
3	Neoplasms (Cancer) 10/2022 - 03/2002
3	Alveolar echinococcosis 01/2012 - 12/2009
3	Cysts 09/2011 - 11/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2022
2	Communicable Diseases (Infectious Diseases) 09/2022 - 03/2002
2	Tick-Borne Diseases (Tick-Borne Disease) 01/2021 - 03/2016
2	Human Influenza (Influenza) 06/2011 - 01/2011
2	Babesiosis (Piroplasmosis) 08/2009 - 08/2004
1	Lung Injury 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Radiation Pneumonitis 01/2023
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Lumpy Skin Disease 09/2022
1	Adenocarcinoma 03/2022
1	Rabies (Hydrophobia) 06/2021
1	Coinfection 01/2021
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 11/2020
1	Dengue (Dengue Fever) 10/2020
1	Legionnaires' Disease (Legionnaire's Disease) 01/2020
1	Cryptosporidiosis 01/2020
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2017
1	Lymphoma (Lymphomas) 02/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013
1	Plague (Bubonic Plague) 01/2012
1	Coccidiosis 01/2012
1	Trypanosomiasis 03/2011
1	Influenza in Birds (Avian Flu) 01/2011
1	Cysticercosis 12/2009
1	Parasitic Diseases (Parasitic Disease) 09/2009
1	Tick Infestations 01/2009
1	Anemia 04/2007
1	Splenomegaly 04/2007
1	African Trypanosomiasis (Nagana) 04/2007
1	Marek Disease (Marek's Disease) 06/2006
1	Avian Leukosis 06/2006
1	Parasitemia 04/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 03/2004

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2003
8	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 10/2006
7	VaccinesIBA 01/2012 - 08/2004
5	AntigensIBA 08/2010 - 04/2007
3	ImmunosorbentsIBA 08/2010 - 12/2003
3	EnzymesIBA 08/2010 - 12/2003
2	tert-butylserineIBA 01/2021 - 03/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2012 - 03/2004
2	TetraspaninsIBA 01/2012 - 12/2009
2	Indicators and Reagents (Reagents)IBA 08/2010 - 10/2003
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2009 - 04/2007
2	CytokinesIBA 04/2007 - 03/2002
1	durvalumabIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	osimertinibIBA 10/2022
1	B7-H1 AntigenIBA 10/2022
1	Lysergic Acid Diethylamide (LSD)IBA 09/2022
1	pembrolizumabIBA 03/2022
1	PlatinumIBA 03/2022
1	Neutralizing AntibodiesIBA 06/2021
1	tributyl phosphate (TBP)IBA 01/2021
1	tert-butylbicyclophosphorothionateIBA 01/2021
1	AerosolsIBA 01/2020
1	SirtuinsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Mitochondrial DNA (mtDNA)IBA 03/2016
1	RNA (Ribonucleic Acid)IBA 09/2014
1	Culture MediaIBA 02/2013
1	Protein Isoforms (Isoforms)IBA 02/2013
1	1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Caspase 3 (Caspase-3)IBA 01/2013
1	Caspase 9IBA 01/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2012
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2012
1	Freund's AdjuvantIBA 01/2012
1	Ribosomal DNA (rDNA)IBA 03/2011
1	Viral ProteinsIBA 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	EpitopesIBA 01/2011
1	HLA-A24 AntigenIBA 01/2011
1	LatexIBA 08/2010
1	Recombinant ProteinsIBA 11/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2009
1	Drug CombinationsIBA 02/2009
1	Monoclonal AntibodiesIBA 08/2008
1	ribosomal protein P0IBA 06/2007
1	Immunoglobulins (Immunoglobulin)IBA 04/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2007
1	Liposomes (Liposome)IBA 04/2006
1	Surface Antigens (Surface Antigen)IBA 03/2004
1	AntibodiesIBA 10/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2023 - 01/2012
3	Therapeutics 01/2023 - 10/2022
1	Chemoradiotherapy 01/2023
1	Oral Administration 09/2011